Metformin’s Potential Role in PCO - Summary - MDSpire

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

  • By

  • Conexiant News Staff

  • March 5, 2026

  • 3 min

Share

Objective:

To investigate the role of metformin in reducing posterior capsule opacification (PCO) after cataract surgery.

Key Findings:
  • Metformin was detectable in all lens capsule specimens, indicating systemic exposure translates into intraocular tissue levels.
  • Capsule concentrations did not differ significantly between low-dose and high-dose groups.
  • Metformin significantly attenuated LEC proliferation in vitro compared to controls.
Interpretation:

The findings suggest that metformin may play a protective role against PCO by suppressing LEC proliferation, potentially explaining conflicting epidemiological data regarding diabetes and PCO risk.

Limitations:
  • Study involved a small sample size of 20 patients.
  • Variability in serum levels due to interindividual differences in metformin pharmacokinetics.
Conclusion:

The study provides evidence that metformin accumulates in the human lens capsule and suppresses LEC proliferation, warranting larger studies to explore its potential as a pharmacological adjunct in PCO prevention.

Original Source(s)

Metformin’s Potential Role in PCO

  • by Conexiant News Staff

  • March 5, 2026

Related Content

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min
From Babylon to Berlin

Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine